Pasithea Therapeutics Announces Comprehensive Settlement Agreement with the Camac Group
12.12.2022 - MIAMI BEACH, Fla., Dec. 12, 2022 (GLOBE NEWSWIRE) - Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a biotechnology company focused on the discovery, research and development of innovative treatments for central nervous ...
Source: wallstreet-online.de